WO2007041768A1 - Treatment for periodontal disease - Google Patents
Treatment for periodontal disease Download PDFInfo
- Publication number
- WO2007041768A1 WO2007041768A1 PCT/AU2006/001459 AU2006001459W WO2007041768A1 WO 2007041768 A1 WO2007041768 A1 WO 2007041768A1 AU 2006001459 W AU2006001459 W AU 2006001459W WO 2007041768 A1 WO2007041768 A1 WO 2007041768A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dental
- paste
- clindamycin
- root canal
- effective amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/52—Cleaning; Disinfecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Definitions
- the filed of the invention relates to preparation and formulation used in the dental field.
- the invention relates to preparations and formulations used in the field of dental surgery.
- Root canal surgery is often seen as a rather dramatic step due to a number of factors such as the complexity of the surgery and the belief amongst many of the associated negative side effects.
- the active antibiotic ingredient in Ledermix is demeclocycline hydrochloride, a tetracycline antibacterial. It has been shown that in practice when Ledermix paste is applied apical to the cemento-enamal junction and then exposed to sunlight an unsightly brown staining is produced. This staining can be minimised by placing the Ledermix paste below the gingival margin so as reduce exposure to sunlight and also ensuring that the Ledermix paste is not left on any of the walls of the access cavities.
- a dental paste including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for inserting into an evacuated root canal area, such that when in use the dental paste, when exposed to sunlight, does not stain tooth enamel.
- the therapeutically effective amount of clindamycin is between 3- 6% w/w.
- the therapeutically effective amount of clindamycin is 5% w/w.
- the dental paste further includes at least one additive or preservative.
- the dental paste further includes at least one corticosteroid.
- the at least on additive or preservative includes polyethylene glycol.
- a further form of the invention can be said to exist in a composition including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for oral application, when used as a dental paste in the treatment of bacterial infections in the tooth.
- a further form of the invention can be said to exist in the method of treating or reducing the risk of microbial infection in a root canal providing the step of inserting into an evacuated root canal area a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for oral application.
- the microbiological flora found in the root canal is quite diverse and dentoalbeolar infection is characterised in that the infection is usually polymicrobial with a mixture of some three to four different species. Monomicrobial infection is highly unusual and strict anaerobes are the predominant organisms.
- a pulpectomy is required, often referred to as a "root canal" in which the unhealthy tooth is cut open or access is gained into by widening of an already existing cavity to provide access to the internal infected pulp, which is subsequently removed by scraping out of the root canals.
- the now empty or excavated root canal is then filled with the paste of the following formulation (weight/weight):
- a dental paste is placed into the vacant area in order to thoroughly and efficiently destroy any remaining bacteria so as to prevent any subsequent infection.
- the paste is then left in the patients tooth for a period of time and then removed prior to filling with a suitable inter material.
- Clindamycin has been used in the treatment of dental abscesses for over fifteen years, primarily as an oral pharmaceutical tooth root infection.
- the use of current dental pastes which all include the tetracycline antibacterial demeclocycline, which, upon exposure to sunlight results in unsightly staining of teeth enamel.
- the use of the paste of the current invention which includes the antibacterial clindamycin, provides an equal, if not greater, antibacterial effect to that of currently used pastes and has the important advantage of not being susceptible to light in that it does not cause unsightly staining of the tooth enamel.
- clindamycin has the added therapeutic advantage of having a higher bone/dentin permeability factor than that of demeclocycline and therefore is able to act on bacteria deeper in the root canal as well as providing greater efficacy.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
Abstract
A dental paste for use in dental surgery that includes a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for insertion into an evacuated dental root canal area, such that when in use the dental paste, when exposed to sunlight, does not stain tooth enamel.
Description
TITLE
TREATMENT FOR PERIODONTAL DISEASE
FIELD OF THE INVENTION
The filed of the invention relates to preparation and formulation used in the dental field.
In particular, the invention relates to preparations and formulations used in the field of dental surgery.
DESCRIPTION OF THE PRIOR ART
Root canal surgery is often seen as a rather dramatic step due to a number of factors such as the complexity of the surgery and the belief amongst many of the associated negative side effects.
One of the major drawbacks with the current methodology associated with root canal surgery is that the antibiotic paste currently in use, Ledermix, results in unsightly staining of the teeth of the patient.
The active antibiotic ingredient in Ledermix is demeclocycline hydrochloride, a tetracycline antibacterial. It has been shown that in practice when Ledermix paste is applied apical to the cemento-enamal junction and then exposed to sunlight an unsightly brown staining is produced. This staining can be minimised by placing the Ledermix paste below the gingival margin so as reduce exposure to sunlight and also ensuring that the Ledermix paste is not left on any of the walls of the access cavities.
However, it is not always possible to restrict the placement of Ledermix in such a manner and thus it is inevitable that some of the paste is exposed to sunlight, resulting in staining of the teeth.
As such, the teeth of the effected patient often require cleaning, which can be considerable expensive and inconvenient. Added to the root canal surgery itself, the end result is one that takes a substantial amount of time. The
associated economic impact on the patient is evident as is the general hesitation by others to undergo what may be a necessary surgery to avoid more dire consequences at a later stage due to infection of the root canal area.
OBJECT OF THE INVENTION
It is an object of the present invention to provide an acceptable dental paste formulation that is able to function effectively as an antibiotic without staining the enamel of the tooth that it is applied to.
It is a further object of the invention to provide an acceptable dental paste formulation that permeates bone/dentin greater than dental pastes of the prior art.
It is an object of the present invention to overcome, or at least substantially ameliorate, the disadvantages and shortcomings of the prior art.
Other objects and advantages of the present invention will become apparent from the following description, taking in connection with the accompanying drawings, wherein, by way of illustration and example, an embodiment of the present invention is disclosed.
SUMMARY OF THE INVENTION
According to the present invention, although this should not be seen as limiting the invention in any way, there is provided a dental paste including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for inserting into an evacuated root canal area, such that when in use the dental paste, when exposed to sunlight, does not stain tooth enamel.
In preference, the therapeutically effective amount of clindamycin is between 3- 6% w/w.
In preference, the therapeutically effective amount of clindamycin is 5% w/w.
In preference, the dental paste further includes at least one additive or preservative.
In preference, the dental paste further includes at least one corticosteroid.
In preference, the at least on additive or preservative includes polyethylene glycol.
A further form of the invention can be said to exist in a composition including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for oral application, when used as a dental paste in the treatment of bacterial infections in the tooth.
A further form of the invention can be said to exist in the method of treating or reducing the risk of microbial infection in a root canal providing the step of inserting into an evacuated root canal area a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for oral application.
DETAILED DESCRIPTION OF THE INVENTION
The microbiological flora found in the root canal is quite diverse and dentoalbeolar infection is characterised in that the infection is usually polymicrobial with a mixture of some three to four different species. Monomicrobial infection is highly unusual and strict anaerobes are the predominant organisms.
Bacteria commonly isolated from dentoalveolar abscesses.
Facultative anaerobes
Streptococcus milleri
Streptococcus sanguis
Actinomyces spp.
Obligate anaerobes
Peptostreptococcus spp.
Porphyromonas gingivalis
Prevotella intermedia
Prevotella melaninogenica
Fusobacterium nucleatum
To cure an infection of the root canal a pulpectomy is required, often referred to as a "root canal" in which the unhealthy tooth is cut open or access is gained into by widening of an already existing cavity to provide access to the internal infected pulp, which is subsequently removed by scraping out of the root canals. The now empty or excavated root canal is then filled with the paste of the following formulation (weight/weight):
It is during the stage of cleaning up the root that a dental paste is placed into the vacant area in order to thoroughly and efficiently destroy any remaining bacteria so as to prevent any subsequent infection. The paste is then left in the patients tooth for a period of time and then removed prior to filling with a suitable inter material.
Clindamycin has been used in the treatment of dental abscesses for over fifteen years, primarily as an oral pharmaceutical tooth root infection. The use of current dental pastes which all include the tetracycline antibacterial demeclocycline, which, upon exposure to sunlight results in unsightly staining of teeth enamel. The use of the paste of the current invention, which includes the antibacterial clindamycin, provides an equal, if not greater, antibacterial effect to that of currently used pastes and has the important advantage of not being susceptible to light in that it does not cause unsightly staining of the tooth enamel.
In addition, clindamycin has the added therapeutic advantage of having a higher bone/dentin permeability factor than that of demeclocycline and therefore is able to act on bacteria deeper in the root canal as well as providing greater efficacy.
This then represents a significant advancement in the root canal treatment and therapy that provides significant advantageous to both the patient and practitioner.
In addition, due to the fact that clindamycin is UV stable and exposure to UV light will not result in staining of the patients teeth as such there is no need for the dentist to apply the paste only below the gingival margin and extra paste can be applied when necessary to the walls of the access cavities so as to
ensure complete and thorough treatment. This then of course has a flow-on effect to the patient in that more efficient treatment is provided without any of the drawbacks of the currently used containing pastes.
Although the invention has been herein shown and described in what is conceived to be the most practical and preferred embodiment, it is recognized that departures can be made within the scope of the invention, which is not to be limited to the details described herein but it is to be accorded the full scope of the appended claims so as to embrace any and all equivalent methods and formulations.
Claims
1. A dental paste including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for insertion into an evacuated dental root canal area, such that when in use the dental paste, when exposed to sunlight, does not stain tooth enamel.
2. The dental paste of claim 1 , wherein the therapeutically effective amount of clindamycin is between 3-6% w/w.
3. The dental paste of claim 2, wherein the therapeutically effective amount of clindamycin is 5% w/w.
4. The dental paste of claim 3, further including at least one additive or preservative.
5. The dental paste of claim 4, further including at least one corticosteroid.
6. The dental paste of claim 5, wherein the at least one additive or preservative includes polyethylene glycol.
7. A composition including a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for inserting into an evacuated dental root canal area, when used as a dental paste in the treatment of bacterial infections in the tooth.
8. A method of treating or reducing the risk of microbial infection in a dental root canal providing the step of inserting into an evacuated root canal area a therapeutically effective amount of clindamycin and a pharmaceutically acceptable carrier for oral application.
9. A dental paste for treatment of bacterial infections within the dental root of a patient's tooth as substantially described herein with reference to the accompanying description.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06790329A EP1933803A1 (en) | 2005-10-07 | 2006-10-06 | Treatment for periodontal disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005220230A AU2005220230B2 (en) | 2005-10-07 | 2005-10-07 | Treatment for periodontal disease |
AU2005220230 | 2005-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007041768A1 true WO2007041768A1 (en) | 2007-04-19 |
Family
ID=37942205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2006/001459 WO2007041768A1 (en) | 2005-10-07 | 2006-10-06 | Treatment for periodontal disease |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1933803A1 (en) |
CN (1) | CN101237848A (en) |
AU (1) | AU2005220230B2 (en) |
MY (1) | MY151830A (en) |
WO (1) | WO2007041768A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014117218A1 (en) * | 2013-01-31 | 2014-08-07 | Matthew Athanassiadis | Slow release endodontic paste |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106344419B (en) * | 2016-11-08 | 2019-06-25 | 四川大学 | A kind of modified paste filler and its preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020164557A1 (en) * | 1999-04-02 | 2002-11-07 | Forsyth Dental Infirmary For Children | Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy |
US20050032720A1 (en) * | 2003-08-06 | 2005-02-10 | Regenacorp, Inc. | Method and composition for treating peridontal disease |
-
2005
- 2005-10-07 AU AU2005220230A patent/AU2005220230B2/en active Active
-
2006
- 2006-10-06 WO PCT/AU2006/001459 patent/WO2007041768A1/en active Application Filing
- 2006-10-06 MY MYPI20080809 patent/MY151830A/en unknown
- 2006-10-06 EP EP06790329A patent/EP1933803A1/en not_active Withdrawn
- 2006-10-06 CN CNA2006800283659A patent/CN101237848A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020164557A1 (en) * | 1999-04-02 | 2002-11-07 | Forsyth Dental Infirmary For Children | Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy |
US20050032720A1 (en) * | 2003-08-06 | 2005-02-10 | Regenacorp, Inc. | Method and composition for treating peridontal disease |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014117218A1 (en) * | 2013-01-31 | 2014-08-07 | Matthew Athanassiadis | Slow release endodontic paste |
GB2525564A (en) * | 2013-01-31 | 2015-10-28 | Matthew Athanassiadis | Slow release endodontic paste |
US9662278B2 (en) | 2013-01-31 | 2017-05-30 | Matthew Athanassiadis | Slow release endodontic paste |
AU2014213007B2 (en) * | 2013-01-31 | 2017-11-23 | Vanco, Constantinos | Slow release endodontic paste |
GB2525564B (en) * | 2013-01-31 | 2018-05-09 | Athanassiadis Matthew | Slow release endodontic paste |
Also Published As
Publication number | Publication date |
---|---|
EP1933803A1 (en) | 2008-06-25 |
AU2005220230A1 (en) | 2007-04-26 |
CN101237848A (en) | 2008-08-06 |
AU2005220230B2 (en) | 2009-10-01 |
MY151830A (en) | 2014-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bansal et al. | Overview on the current antibiotic containing agents used in endodontics | |
Peikoff et al. | An endodontic failure caused by an unusual anatomical anomaly | |
Yamauchi et al. | Effect of orifice plugs on periapical inflammation in dogs | |
Killoy | Chemical treatment of periodontitis: local delivery of antimicrobials | |
Park et al. | Treatment of non-vital immature teeth with amoxicillin-containing triple antibiotic paste resulting in apexification | |
Di Felice et al. | Gingival and mandjbular bone necrosis caused by a paraformaldehyde‐containing paste | |
Steinberg et al. | Dental drug-delivery devices: local and sustained-release applications | |
Deliperi | Clinical evaluation of nonvital tooth whitening and composite resin restorations: five-year results | |
AU2005220230B2 (en) | Treatment for periodontal disease | |
EP2914233B1 (en) | Dental compositions | |
JP5390767B2 (en) | Bacterial oral disease treatment composition, cleaning treatment solution, hemostatic treatment solution, and bacterial oral disease treatment method | |
Madison et al. | Medications and temporaries in endodontic treatment | |
Takushige et al. | Endodontic retreatment using 3Mix-MP without removal of previous root canal obturation | |
RU2370238C1 (en) | Method of apical periodontitis treatment | |
Rao et al. | The pertinacious dilemma-endo-perio lesion | |
Sharma et al. | ENDODONTIC AND SURGICAL MANAGEMENT OF ODONTOGENIC CUTANEOUS SINUS AND MINERAL TRIOXIDE AGGREGATE OBTURATION IN A 8 YEAR OLD GIRL | |
Aggarwal et al. | Endodontic management of a patient with oral submucous fibrosis using custom modified endodontic instruments | |
Hafiz et al. | Monolithic zirconia crown with intracanal retention: A case report | |
CN103536680B (en) | Preparation for treating periodontosis | |
SE0102999L (en) | Composition and procedure for disinfection of the root canals | |
El-Sawy | Endodontic Management of a Rare Abnormal Anatomy in Mandibular Second Molar: A Case Report | |
Biniraj et al. | Clinical attachment level gain and bone regeneration around a glass ionomer restoration on root surface wall of periodontal pocket | |
JP2013531048A (en) | Combination of siloxane and active ingredients to treat dental disorders | |
Sruthi et al. | Preference Of Intracanal Medicaments Placed During Management Of Non-Vital Opex Apex | |
D'souza et al. | Management of a mid-treatment flare-up |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200680028365.9 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006790329 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2006790329 Country of ref document: EP |